Anti inflammatory effects of Cannabis sativa L. seed oil in hemodialysis patients
Phase 3
- Conditions
- End Stage Renal Disease (Hemodialysis).Chronic kidney disease, stage 5
- Registration Number
- IRCT2017031522637N3
- Lead Sponsor
- Vice chancellor for research, Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
patients undergoing regular hemodialysis for at least 3 months
Exclusion criteria: active infection; consuming immunosuppressive medications; autoimmune diseases
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum concentration of interleukin-6. Timepoint: At baseline and at the end of the study. Method of measurement: ELISA kit.;Serum concentration of interleukin-33. Timepoint: At baseline and at the end of the study. Method of measurement: ELISA kit.
- Secondary Outcome Measures
Name Time Method Adverse effects. Timepoint: During the study. Method of measurement: patient self report.